Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCRN
4501
DELISTED
Cross Country Healthcare
CCRN
| $341K | ﹤0.01% |
39,071
+20,240
| +107% | +$207K |
|
|
AGFS
4502
DELISTED
AgroFresh Solutions Inc
AGFS
| $341K | ﹤0.01% |
54,685
+47,551
| +667% | +$315K |
|
4503
Ambev
ABEV
$43.5B
| $340K | ﹤0.01% |
74,322
-216,561
| -74% | -$1.03M |
|
4504
Noodles & Co
NDLS
$98M
| $340K | ﹤0.01% |
3,515
+2,651
| +307% | +$245K |
|
4505
Spok Holdings
SPOK
$230M
| $340K | ﹤0.01% |
22,090
+14,602
| +195% | +$221K |
|
4506
PUT
Ternium
TX
$10.8B
| $339K | ﹤0.01% |
+11,200
| New | +$355K |
|
|
FISV
4507
CALL
Fiserv Inc
FISV
$29.5B
| $338K | ﹤0.01% |
4,100
-3,100
| -43% | -$243K |
|
4508
PUT
Sturm, Ruger & Co
RGR
$600M
| $338K | ﹤0.01% |
4,900
-3,000
| -38% | -$182K |
|
|
LKFT
4509
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $337K | ﹤0.01% |
+3,000
| New | +$317K |
|
4510
PUT
EQT Corp
EQT
$33.8B
| $336K | ﹤0.01% |
13,961
+183
| +1% | +$5.05K |
|
4511
PUT
Golar LNG
GLNG
$5.2B
| $336K | ﹤0.01% |
12,100
-142,600
| -92% | -$3.78M |
|
4512
PUT
Owens Corning
OC
$12.3B
| $336K | ﹤0.01% |
6,200
+2,500
| +68% | +$151K |
|
|
CYBR
4513
PUT
DELISTED
CyberArk
CYBR
| $335K | ﹤0.01% |
4,200
-600
| -13% | -$42.1K |
|
|
FFG
4514
DELISTED
FBL Financial Group
FFG
| $335K | ﹤0.01% |
4,466
+3,358
| +303% | +$272K |
|
4515
Federal Agricultural Mortgage
AGM
$2.58B
| $334K | ﹤0.01% |
4,623
+2,924
| +172% | +$248K |
|
4516
Washington Trust Bancorp
WASH
$750M
| $334K | ﹤0.01% |
6,041
+4,730
| +361% | +$278K |
|
|
KDNY
4517
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $334K | ﹤0.01% |
9,086
+3,854
| +74% | +$124K |
|
|
FIT
4518
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $334K | ﹤0.01% |
62,400
-17,800
| -22% | -$106K |
|
4519
CALL
Post Holdings
POST
$3.65B
| $333K | ﹤0.01% |
+5,195
| New | +$319K |
|
4520
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
| $332K | ﹤0.01% |
+50,000
| New | +$280K |
|
|
4521
PUT
Aurinia Pharmaceuticals
AUPH
$2.06B
| $332K | ﹤0.01% |
+50,000
| New | +$280K |
|
|
GES
4522
CALL
DELISTED
Guess Inc
GES
| $332K | ﹤0.01% |
14,700
-19,600
| -57% | -$444K |
|
4523
CALL
Prothena Corp
PRTA
$475M
| $332K | ﹤0.01% |
25,400
+10,700
| +73% | +$155K |
|
4524
CALL
Trinity Industries
TRN
$2.3B
| $330K | ﹤0.01% |
12,501
-16,112
| -56% | -$423K |
|
4525
PUT
Energous
WATT
$93.4M
| $330K | ﹤0.01% |
54
-14
| -21% | -$109K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.